We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$38.1B
AUM Growth
Cap. Flow
+$38.4B
Cap. Flow %
100.8%
Top 10 Hldgs %
11.4%
Holding
2,756
New
2,750
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$671M
2
MCD icon
McDonald's
MCD
+$636M
3
TSM icon
TSMC
TSM
+$515M
4
NVO
Novo Nordisk
NVO
+$465M
5
CL icon
Colgate-Palmolive
CL
+$458M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 14.45%
2 Healthcare 11.94%
3 Consumer Discretionary 11.58%
4 Consumer Staples 10.68%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ERNA icon
2426
Eterna Therapeutics
ERNA
$4.23M
$274K ﹤0.01%
+1
New +$262K
HOLL
2427
DELISTED
HOLLYWOOD MEDIA CORP
HOLL
$274K ﹤0.01%
+204,304
New +$284K
SEED icon
2428
Origin Agritech
SEED
$12.1M
$273K ﹤0.01%
+19,500
New +$318K
EQC
2429
DELISTED
Equity Commonwealth
EQC
$273K ﹤0.01%
+11,787
New +$254K
ESMC
2430
DELISTED
Escalon Medical Corp
ESMC
$273K ﹤0.01%
+203,700
New +$242K
SHG icon
2431
Shinhan Financial Group
SHG
$32.8B
$270K ﹤0.01%
+8,300
New +$284K
JASO
2432
DELISTED
JA Solar Holdings, Co., Ltd
JASO
$270K ﹤0.01%
+37,460
New +$218K
SDIX
2433
DELISTED
STRATEGIC DIAGNOSTICS INC
SDIX
$270K ﹤0.01%
+299,300
New +$301K
GKNT
2434
DELISTED
GEEKNET INC COM NEW
GKNT
$270K ﹤0.01%
+19,455
New +$267K
AXIA
2435
AXIA Energia
AXIA
$23.3B
$269K ﹤0.01%
+160,473
New +$331K
STRM
2436
DELISTED
Streamline Health Solutions
STRM
$269K ﹤0.01%
+2,733
New +$268K
IGOI
2437
DELISTED
IGO, INC NEW
IGOI
$268K ﹤0.01%
+114,432
New +$281K
BAA
2438
DELISTED
Banro Corporation Common Stock
BAA
$267K ﹤0.01%
+35,650
New +$403K
SYBT icon
2439
Stock Yards Bancorp
SYBT
$2.52B
$265K ﹤0.01%
+16,200
New +$252K
EMAN
2440
DELISTED
eMagin Corporation
EMAN
$265K ﹤0.01%
+74,300
New +$261K
MCBI
2441
DELISTED
METROCORP BANCSHARES INC
MCBI
$265K ﹤0.01%
+27,200
New +$273K
HFWA icon
2442
Heritage Financial
HFWA
$1.22B
$264K ﹤0.01%
+18,000
New +$251K
NSIT icon
2443
Insight Enterprises
NSIT
$3.77B
$264K ﹤0.01%
+14,873
New +$277K
SCR
2444
DELISTED
SIMCERE PHARMACEUTICAL GROUP, ADS
SCR
$264K ﹤0.01%
+27,800
New +$257K
STN icon
2445
Stantec
STN
$8.2B
$263K ﹤0.01%
+12,400
New +$264K
DFBG
2446
DELISTED
Differential Brands Group Inc
DFBG
$263K ﹤0.01%
+5,353
New +$278K
GST
2447
DELISTED
Gastar Exploration Inc.
GST
$260K ﹤0.01%
+97,500
New +$258K
ALNT icon
2448
Allient
ALNT
$1.41B
$258K ﹤0.01%
+57,600
New +$266K
THMO
2449
DELISTED
ThermoGenesis Holdings, Inc. Common Stock
THMO
$258K ﹤0.01%
+21
New +$192K
BMRC icon
2450
Bank of Marin Bancorp
BMRC
$472M
$256K ﹤0.01%
+12,800
New +$252K

Similar funds

Renaissance Technologies's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Eli Lilly: 12,326,205 shares worth $605M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
  • Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.

Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.